Insider Stock Trading History of Gollust Keith R


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Gollust Keith R since year 2005. The trader's CIK number is 1325712. At the time of this reporting, Gollust Keith R is the of Synta Pharmaceuticals Corp . (stock ticker symbol SNTA). See this page for all insider trading activities at Synta Pharmaceuticals Corp .


Stock purchases, sales, and option exercises reported by insider Gollust Keith R since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-12-11 SNTA Synta Pharmaceuticals Corp Sale 300,000 .37 111,000
2015-12-14 SNTA Synta Pharmaceuticals Corp Sale 300,000 .32 96,600
2015-12-08 SNTA Synta Pharmaceuticals Corp Sale 300,000 .38 114,000
2015-12-09 SNTA Synta Pharmaceuticals Corp Sale 145,892 .38 55,293
2015-12-07 SNTA Synta Pharmaceuticals Corp Sale 300,000 .39 115,800
2015-11-17 SNTA Synta Pharmaceuticals Corp Sale 100,000 .41 41,400
2015-11-10 SNTA Synta Pharmaceuticals Corp Sale 188,322 .55 103,012
2013-11-13 SNTA Synta Pharmaceuticals Corp Buy 150,000 3.75 562,500
2013-01-23 SNTA Synta Pharmaceuticals Corp Option Ex 114,250 5.09 581,304
2012-06-29 SNTA Synta Pharmaceuticals Corp Buy 150,000 5.35 801,900
2011-04-14 SNTA Synta Pharmaceuticals Corp Buy 100,000 4.89 488,999
2010-01-08 SNTA Synta Pharmaceuticals Corp Buy 100,000 4.50 450,000
2008-08-11 SNTA Synta Pharmaceuticals Corp Buy 50,000 7.28 364,150
2008-08-12 SNTA Synta Pharmaceuticals Corp Buy 35,000 7.58 265,230
2008-08-13 SNTA Synta Pharmaceuticals Corp Buy 31,997 7.78 248,808
2008-05-30 SNTA Synta Pharmaceuticals Corp Buy 5,939 7.10 42,160
2008-05-29 SNTA Synta Pharmaceuticals Corp Buy 24,061 7.18 172,709
2008-05-16 SNTA Synta Pharmaceuticals Corp Buy 40,000 7.07 282,760
2008-05-19 SNTA Synta Pharmaceuticals Corp Buy 10,000 6.95 69,470
2007-02-09 SNTA Synta Pharmaceuticals Corp Buy 180,000 10.00 1,800,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gollust Keith R ( of Synta Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.